CLI and Postoperative Histopathology Results for Each Patient in Analysis Dataset
| Patient | Tumor type | Histologic grade invasive (1–3) | ER/HER2 status of invasive cancer (Pos/neg) | Mean tumor radiance (photons/s/cm2/sr) | TBR | Margin distance CLI surgeons 1 and 2* (mm) | Margin distance histopathology (mm) | Tumor size CLI surgeons 1 and 2* (mm) | Invasive tumor size histopathology† (mm) | Whole tumor size histopathology† (mm) |
| 1 | NST DCIS | 2 | Pos/Neg | —‡ | — | — | — | — | 13 | 13 |
| 2 | NST DCIS | 3 | Neg/Pos | 453.59 | 2.34 | 6, 6 | >5 | *¶ | 22 | 22 |
| 3 | NST | 3 | Neg/Neg | 871.16 | 3.22 | 2, 2 | 3 | 20, 18 | 20 | 20 |
| 28, 30 | >5 | |||||||||
| 4 | NST DCIS | 3 | Neg/Neg | —‡ | — | — | — | — | 14 | 14 |
| 5 | NST DCIS | 3 | Pos/Neg | 405.76 | 2.03 | 2, 3 | 5 | 18, 18 | 20 | 20 |
| 6 | ILC | 2 | Pos/Neg | 544.04 | 2.44 | 9, 9 | >5 | 20, 19 | 22 | 22 |
| 7 | NST | 3 | Pos/Neg | 667.47 | 2.72 | 10, 11 | >5 | *¶ | 25 | 25 |
| 8 | NST DCIS | 2 | Pos/Neg | 308.30 | 1.63 | 6, 8 | >5 | 19, 19 | 15 | 35 |
| 16, 15 | >5 | |||||||||
| 9 | NST DCIS | 3 | Pos/Neg | 593.93 | 3.08 | 14, 13 | >5 | 14, 15 | 18 | 19 |
| 6, 7 | >5 | |||||||||
| 10 | NST DCIS | 3 | Pos/Neg | 648.29 | 2.46 | 8, 8 | >5 | 22, 22 | 19 | 29 |
| 11 | NST DCIS | 2 | Pos/Neg | 466.03 | 2.54 | 15, 14 | >5 | 13, 11 | 13 | 13 |
| 12 | NST DCIS | 3 | Pos/Neg | 637.08 | 1.63 | 9, 9 | >5 | 12, 10 | 14 | 14 |
| 30, 31 | >5 | |||||||||
| 22, 22 | >5 |
↵* Margin distance and tumor size are shown for surgeons 1 and 2, respectively.
↵† Histopathologic tumor size displayed in table is tumor size measured in same direction as tumor size measurement on CLI. In patients 3, 11, and 12, largest invasive and whole tumor size (i.e., extent of DCIS and invasive cancer) were measured in different direction, and were 32, 33, and 25 mm, respectively.
↵‡ No elevated tumor radiance on CLI.
↵¶ Presence of orientation inks prevented measuring tumor size on CLI.
ER = estrogen receptor; HER2 = human epidermal growth factor receptor 2; NST = invasive carcinoma of ductal/no special type; Pos = positive; Neg = negative; ILC = invasive lobular carcinoma.